1 |
Y. Liang, T. Ma, A. Thakur, H. Yu, L. Gao, P. Shi, X. Li, H. Ren, L. Jia, S. Zhang, Z. Li, and M. Chen, Differentially expressed glycosylated patterns of alpha-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer, Glycobiol., 25, 331-340 (2015).
DOI
|
2 |
C. Jiao, L. Cui, A. Ma, N. Li, and H. Si, Elevated serum levels of retinol-binding protein 4 are associated with breast cancer risk: A case-control study, PLoS One, 11, 1-12 (2016).
|
3 |
H. R. Jang, A. W. Wark, S. H. Baek, B. H. Chung, and H. J. Lee, Ultrasensitive and ultrawide range detection of a cardiac biomarker on a surface plasmon resonance platform, Anal. Chem., 86, 814-819 (2014).
DOI
|
4 |
F. Grossi, M. Loprevite, M. Chiaramondia, P. Ceppa, C. Pera, G. B. Ratto, J. Serrano, G. B. Ferrara, R. Costa, L. Boni, and A. Ardizzoni, Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers, Eur. J. Cancer, 39, 1242-1250 (2003).
DOI
|
5 |
B. Hayes, C. Murphy, A. Crawley, and R. O'Kennedy, Developments in point-of-care diagnostic technology for cancer detection, Diagnostics (Basel), 8, 1-18 (2018).
|
6 |
M. Spinola, V. P. Leoni, A. Galvan, E. Korsching, B. Conti, U. Pastorino, F. Ravagnani, A. Columbano, V. Skaug, A. Haugen, and T. A. Dragani, Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene, Cancer Lett., 251, 311-316 (2007).
DOI
|
7 |
E. Carcereny, J. L. Ramirez, M. Sanchez-Ronco, D. Isla, M. Cobo, T. Moran, I. de Aguirre, T. Okamoto, J. Wei, M. Provencio, G. Lopez-Vivanco, C. Camps, M. Domine, V. Alberola, J. M. Sanchez, B. Massuti, P. Mendez, M. Taron, and R. Rosell, Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients, Lung Cancer, 68, 491-497 (2010).
DOI
|
8 |
H. D. Hosgood, 3rd, R. Cawthon, X. He, S. Chanock, and Q. Lan, Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility, Lung Cancer, 66, 157-161 (2009).
DOI
|
9 |
J. S. Jang, Y. Y. Choi, W. K. Lee, J. E. Choi, S. I. Cha, Y. J. Kim, C. H. Kim, S. Kam, T. H. Jung, and J. Y. Park, Telomere length and the risk of lung cancer, Cancer Sci., 99, 1385-1389 (2008).
DOI
|
10 |
P. Gresner, J. Gromadzinska, E. Jablonska, J. Kaczmarski, and W. Wasowicz, Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer, Lung Cancer, 65, 34-40 (2009).
DOI
|
11 |
D. G. Weber, G. Johnen, S. Casjens, O. Bryk, B. Pesch, K. H. Jockel, J. Kollmeier, and T. Bruning, Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, BMC Res. Notes, 6, 1-9 (2013).
DOI
|
12 |
D. Madhavan, K. Cuk, B. Burwinkel, and R. Yang, Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures, Front. Genet., 4, 1-13 (2013).
|
13 |
S. K. Arya and S. Bhansali, Lung cancer and its early detection using biomarker-based biosensors, Chem. Rev., 111, 6783-6809 (2011).
DOI
|
14 |
G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, Long period fiber grating nano-optrode for cancer biomarker detection, Biosens. Bioelectron., 80, 590-600 (2016).
DOI
|
15 |
A. P. Abel, M. G. Weller, G. L. Duveneck, M. Ehrat, and H. M. Widmer, Fiber-optic evanescent wave biosensor for the detection of oligonucleotides, Anal. Chem., 68, 2905-2912 (1996).
DOI
|
16 |
V. Donzella and F. Crea, Optical biosensors to analyze novel biomarkers in oncology, J. Biophotonics, 4, 442-452 (2011).
DOI
|
17 |
S. H. Yang, Biomarkers for lung cancer, J. Lung Cancer, 8, 67 (2009).
DOI
|
18 |
D. Tang, Y. Shen, M. Wang, R. Yang, Z. Wang, A. Sui, W. Jiao, and Y. Wang, Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer, Eur. J. Cancer Prev., 22, 540-548 (2013).
|
19 |
A. Koulman, G. A. Lane, S. J. Harrison, and D. A. Volmer, From differentiating metabolites to biomarkers, Anal. Bioanal. Chem., 394, 663-670 (2009).
DOI
|
20 |
Y. Shi, X. Liu, J. Lou, X. Han, L. Zhang, Q. Wang, B. Li, M. Dong, and Y. Zhang, Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses, Clin. Cancer Res., 20, 6016-6022 (2014).
DOI
|
21 |
R. Li, F. Feng, Z. Z. Chen, Y. F. Bai, F. F. Guo, F. Y. Wu, and G. Zhou, Sensitive detection of carcinoembryonic antigen using surface plasmon resonance biosensor with gold nanoparticles signal amplification, Talanta, 140, 143-149 (2015).
DOI
|
22 |
Y. J. Chae and J. S. Park, A comparison of symptoms, depression, and quality of life according to stages of survivorship in lung cancer patients, Asian Oncol. Nurs., 17, 79-86 (2017).
DOI
|
23 |
S. Hammerschmidt and H. Wirtz, Lung cancer: Current diagnosis and treatment, Dtsch. Arztebl. Int., 106, 809-818 (2009).
|
24 |
B.-B. Park, Cytotoxic chemotherapy for non-small cell lung cancer, Hanyang Med. Rev., 34, 31-36 (2014).
DOI
|
25 |
W. Zhou, P. J. Huang, J. Ding, and J. Liu, Aptamer-based biosensors for biomedical diagnostics, Analyst, 139, 2627-2640 (2014).
DOI
|
26 |
C. G. Kim, H. S. Shim, M. H. Hong, Y. J. Cha, S. J. Heo, H. S. Park, J. H. Kim, J. G. Lee, C. Y. Lee, B. C. Cho, and H. R. Kim, Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis, Oncotarget, 8, 65111-65122 (2017).
|
27 |
M. H. Kwon, G. E. Lee, S. J. Kwon, E. Choi, M. J. Na, H. M. Cho, Y. J. Kim, H. J. Sul, Y. J. Cho, and J. W. Son, Identification of DNA methylation markers for NSCLC using Hpall-Mspl methylation microarray, Tuberc. Respir. Dis., 65, 495-503 (2008).
DOI
|
28 |
S. Rodriguez-Enriquez, S. C. Pacheco-Velazquez, J. C. Gallardo-Perez, A. Marin-Hernandez, J. L. Aguilar-Ponce, E. Ruiz-Garcia, L. M. Ruizgodoy-Rivera, A. Meneses-Garcia, and R. Moreno-Sanchez, Multi-biomarker pattern for tumor identification and prognosis, J. Cell Biochem., 112, 2703-2715 (2011).
DOI
|
29 |
M. Perfezou, A. Turner, and A. Merkoci, Cancer detection using nanoparticle-based sensors, Chem. Soc. Rev., 41, 2606-2622 (2012).
DOI
|
30 |
H. V. Tran, B. Piro, S. Reisberg, L. Huy Nguyen, T. Dung Nguyen, H. T. Duc, and M. C. Pham, An electrochemical ELISA-like immunosensor for miRNAs detection based on screen-printed gold electrodes modified with reduced graphene oxide and carbon nanotubes, Biosens. Bioelectron., 62, 25-30 (2014).
DOI
|
31 |
H. Wang, X. Wang, J. Wang, W. Fu, and C. Yao, A SPR biosensor based on signal amplification using antibody-QD conjugates for quantitative determination of multiple tumor markers, Sci. Rep., 6, 1-9 (2016).
DOI
|
32 |
M. J. Kwon, J. Lee, A. W. Wark, and H. J. Lee, Nanoparticle-enhanced surface plasmon resonance detection of proteins at attomolar concentrations: Comparing different nanoparticle shapes and sizes, Anal. Chem., 84, 1702-1707 (2012).
DOI
|
33 |
Z. Altintas and I. Tothill, Biomarkers and biosensors for the early diagnosis of lung cancer, Sens. Actuators B, 188, 988-998 (2013).
DOI
|
34 |
L. Y. Yeo, H. C. Chang, P. P. Chan, and J. R. Friend, Microfluidic devices for bioapplications, Small, 7, 12-48 (2011).
DOI
|
35 |
F. S. Diba, S. Kim, and H. J. Lee, Amperometric bioaffinity sensing platform for avian influenza virus proteins with aptamer modified gold nanoparticles on carbon chips, Biosens. Bioelectron., 72, 355-361 (2015).
DOI
|
36 |
S. Kim and H. J. Lee, Direct detection of alpha-1 antitrypsin in serum samples using surface plasmon resonance with a new aptamer-antibody sandwich assay, Anal. Chem., 87, 7235-7240 (2015).
DOI
|
37 |
S. Kim, A. W. Wark, and H. J. Lee, Femtomolar detection of tau proteins in undiluted plasma using surface plasmon resonance, Anal. Chem., 88, 7793-7799 (2016).
DOI
|
38 |
S. Kim, J. W. Park, A. W. Wark, S. H. Jhung, and H. J. Lee, Tandem femto- and nanomolar analysis of two protein biomarkers in plasma on a single mixed antibody monolayer surface using surface plasmon resonance, Anal. Chem., 89, 12562-12568 (2017).
DOI
|
39 |
S. Kim and H. J. Lee, Gold nanostar enhanced surface plasmon resonance detection of an antibiotic at attomolar concentrations via an aptamer-antibody sandwich assay, Anal. Chem., 89, 6624-6630 (2017).
DOI
|
40 |
T. Singh, S. D. Sharma, and S. K. Katiyar, Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo, PLoS One, 6, 1-13 (2011).
|
41 |
W. Lu, L. Tao, Y. Wang, X. Cao, J. Ge, J. Dong, and W. Qian, An electrochemical immunosensor for simultaneous multiplexed detection of two lung cancer biomarkers using au nanoparticles coated resin microspheres composed of l-tryptophan and caffeic acid, Ionics, 21, 1141-1152 (2014).
|
42 |
Z. Chen, R. Liang, X. Guo, J. Liang, Q. Deng, M. Li, T. An, T. Liu, and Y. Wu, Simultaneous quantitation of cytokeratin-19 fragment and carcinoembryonic antigen in human serum via quantum dot-doped nanoparticles, Biosens. Bioelectron., 91, 60-65 (2017).
DOI
|
43 |
W. Qin, K. Wang, K. Xiao, Y. Hou, W. Lu, H. Xu, Y. Wo, S. Feng, and D. Cui, Carcinoembryonic antigen detection with "handing"-controlled fluorescence spectroscopy using a color matrix for point-of-care applications, Biosens. Bioelectron., 90, 508-515 (2017).
DOI
|
44 |
F. S. Diba, S. Kim, and H. J. Lee, Electrochemical immunoassay for amyloid-beta 1-42 peptide in biological fluids interfacing with a gold nanoparticle modified carbon surface, Catal. Today, 295, 41-47 (2017).
DOI
|
45 |
X. Miao, Z. Li, A. Zhu, Z. Feng, J. Tian, and X. Peng, Ultrasensitive electrochemical detection of protein tyrosine kinase- 7 by gold nanoparticles and methylene blue assisted signal amplification, Biosens. Bioelectron., 83, 39-44 (2016).
DOI
|
46 |
M. Amouzadeh Tabrizi, M. Shamsipur, and L. Farzin, A high sensitive electrochemical aptasensor for the determination of VEGF (165) in serum of lung cancer patient, Biosens. Bioelectron., 74, 764-769 (2015).
DOI
|
47 |
J. H. Lim, J. Park, E. H. Oh, H. J. Ko, S. Hong, and T. H. Park, Nanovesicle-based bioelectronic nose for the diagnosis of lung cancer from human blood, Adv. Healthc. Mater., 3, 360-366 (2014).
DOI
|
48 |
J. Homola, S. S. Yee, and G. Gauglitz, Surface plasmon resonance sensors: Review, Sens. Actuators B, 54, 3-15 (1999).
DOI
|
49 |
Z. Altintas, Y. Uludag, Y. Gurbuz, and I. E. Tothill, Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen, Talanta, 86, 377-383 (2011).
DOI
|
50 |
P. Wu, Y. Gao, Y. Lu, H. Zhang, and C. Cai, High specific detection and near-infrared photothermal therapy of lung cancer cells with high SERS active aptamer-silver-gold shell-core nanostructures, Analyst, 138, 6501-6510 (2013).
DOI
|
51 |
S. Zeng, D. Baillargeat, H. P. Ho, and K. T. Yong, Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications, Chem. Soc. Rev., 43, 3426-3452 (2014).
DOI
|
52 |
Y. Li, H. J. Lee, and R. M. Corn, Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging, Anal. Chem., 79, 1082-1088 (2007).
DOI
|
53 |
J. Zhou, L. Nong, M. Wloch, A. Cantor, J. L. Mulshine, and M. S. Tockman, Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer, Lung Cancer, 34, 341-350 (2001).
DOI
|
54 |
J. A. Ho, H. C. Chang, N. Y. Shih, L. C. Wu, Y. F. Chang, C. C. Chen, and C. Chou, Diagnostic detection of human lung cancer- associated antigen using a gold nanoparticle-based electrochemical immunosensor, Anal. Chem., 82, 5944-5950 (2010).
DOI
|
55 |
Z. Altintas and I. E. Tothill, DNA-based biosensor platforms for the detection of TP53 mutation, Sens. Actuators B, 169, 188-194 (2012).
DOI
|
56 |
F. Liu, H. Zhang, Z. Wu, H. Dong, L. Zhou, D. Yang, Y. Ge, C. Jia, H. Liu, Q. Jin, J. Zhao, Q. Zhang, and H. Mao, Highly sensitive and selective lateral flow immunoassay based on magnetic nanoparticles for quantitative detection of carcinoembryonic antigen, Talanta, 161, 205-210 (2016).
DOI
|
57 |
F. Barlési, C. Gimenez, J.-P. Torre, C. Doddoli, J. Mancini, L. Greillier, F. Roux, and J.-P. Kleisbauer, Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer, Respir. Med., 98, 357-362 (2004).
DOI
|
58 |
F. Alatas, O. Alatas, M. Metintas, O. Colak, E. Harmanci, and S. Demir, Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions, Lung Cancer, 31, 9-16 (2001).
DOI
|